I am currently the Chief Financial Officer of North America for Merz Therapeutics, where I partner across the organization to drive the financial strategy and execution.I am a diverse finance leader with broad experience across the healthcare industry including pharmaceutical, biotechnology/diagnostics, medical devices, services, and software. Prior to joining Merz Therapeutics, I was the Vice President Finance at Syncardia Systems leading finance for the manufacturer of the only commercial artificial heart. Before Syncardia, I held several finance leadership roles at Siemens Healthineers across the diagnostics, imaging, and healthcare software divisions in a mixture of global, USA, and Asia Pacific focused roles. I worked in various large established and startup businesses within the organization. I led the commercial finance group for a global diagnostics division, as well as, established 2 new business units within the company as the head of finance, including the enterprise services group in Japan creating long term partnerships with hospitals and the digital incubator group in the USA focused on early stage healthcare software ventures.I have a Master of Business Administration from Boston University and a bachelor’s degree from George Washington University.